SEC Tracker
Get the app

Bristol Myers Squibb BMY

Bristol Myers Squibb reports stock changes

Theodore R. Samuels II, insider filing for BMY

Form
4
Filed
Importance
Routine
  1. Reported by Theodore R. Samuels II
  2. Sep 30, 2026 transaction date
  3. Deferred Share Units converted to 821.314 shares
  4. 71,859.041 total shares beneficially owned

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Bristol Myers Squibb files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Gilead Sciences GILD public float $103.2B, Jun 30, 2025
  2. Vertex Pharmaceuticals VRTX public float $113.4B, Jun 30, 2025
  3. Zoetis ZTS public float $69.2B, Jun 30, 2025
  4. Pfizer PFE public float $138.0B, Jun 29, 2025
  5. Amgen AMGN public float $150.1B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.